Matches in SemOpenAlex for { <https://semopenalex.org/work/W4387209967> ?p ?o ?g. }
Showing items 1 to 68 of
68
with 100 items per page.
- W4387209967 endingPage "615" @default.
- W4387209967 startingPage "609" @default.
- W4387209967 abstract "Interleukin (IL)-40 is a recently identified cytokine with a novel role in the pathogenesis of inflammatory diseases. Since systemic lupus erythematosus (SLE) is an autoimmune disease characterised by a pro-inflammatory response, it is likely that IL-40 contributes to the underlying disease processes of this disorder. The aim of the current study was to evaluate the potential of IL-40 to act as a diagnostic biomarker for SLE.The study included 99 patients with SLE who attended the Rheumatology Unit at Baghdad Teaching Hospital. These subjects were divided into three subgroups according to disease status: inactive, n = 33; active moderate, n = 33; and active severe, n = 33. Additionally, 33 matched controls were studied. Full medical histories, body mass index, gender and clinical disease activity, the latter evaluated with the SLE disease activity index, were collected. Laboratory parameters measured included anti-dsDNA antibodies, C3 and C4 levels, erythrocyte sedimentation rate and C-reactive protein titres. Serum IL-40 levels were quantified using an enzyme-linked immunosorbent assay.IL-40 levels were significantly higher in patients (12.5420 ± 3.00575 ng/L) than in controls (6.1138 ± 0.59452 ng/L; p < 0.01). Mean serum IL-40 concentration was highest in the active severe group (15.2291 ± 2.26540 ng/L) and decreased, in order of disease severity, in the remaining cohorts: active moderate, 13.0643 ± 1.23927 ng/L; inactive, 9.3325 ± 1.62807 ng/L (P < 0.01); controls, 6.1138 ± 0.59452 ng/L. Serum IL-40 levels showed excellent validity for the diagnosis of SLE with a cut-off value of ≥ 9.3 ng/ml and area under the curve of 0.987. Sensitivity, specificity and accuracy were 99%, 90.9% and 96.97%, respectively (P < 0.001).Serum IL-40 levels were elevated in SLE patients. It is therefore proposed that IL-40 is a novel cytokine which is associated with SLE and positively linked with disease severity." @default.
- W4387209967 created "2023-10-01" @default.
- W4387209967 creator A5004297826 @default.
- W4387209967 creator A5074762829 @default.
- W4387209967 creator A5092973233 @default.
- W4387209967 date "2023-09-01" @default.
- W4387209967 modified "2023-10-01" @default.
- W4387209967 title "Serum interleukin 40: an innovative diagnostic biomarker for patients with systemic lupus erythematosus." @default.
- W4387209967 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37775487" @default.
- W4387209967 hasPublicationYear "2023" @default.
- W4387209967 type Work @default.
- W4387209967 citedByCount "0" @default.
- W4387209967 crossrefType "journal-article" @default.
- W4387209967 hasAuthorship W4387209967A5004297826 @default.
- W4387209967 hasAuthorship W4387209967A5074762829 @default.
- W4387209967 hasAuthorship W4387209967A5092973233 @default.
- W4387209967 hasConcept C126322002 @default.
- W4387209967 hasConcept C159654299 @default.
- W4387209967 hasConcept C185592680 @default.
- W4387209967 hasConcept C198451711 @default.
- W4387209967 hasConcept C203014093 @default.
- W4387209967 hasConcept C2776912625 @default.
- W4387209967 hasConcept C2778143017 @default.
- W4387209967 hasConcept C2778690821 @default.
- W4387209967 hasConcept C2779075594 @default.
- W4387209967 hasConcept C2779134260 @default.
- W4387209967 hasConcept C2780942790 @default.
- W4387209967 hasConcept C2781197716 @default.
- W4387209967 hasConcept C55493867 @default.
- W4387209967 hasConcept C71924100 @default.
- W4387209967 hasConcept C74172505 @default.
- W4387209967 hasConcept C90924648 @default.
- W4387209967 hasConceptScore W4387209967C126322002 @default.
- W4387209967 hasConceptScore W4387209967C159654299 @default.
- W4387209967 hasConceptScore W4387209967C185592680 @default.
- W4387209967 hasConceptScore W4387209967C198451711 @default.
- W4387209967 hasConceptScore W4387209967C203014093 @default.
- W4387209967 hasConceptScore W4387209967C2776912625 @default.
- W4387209967 hasConceptScore W4387209967C2778143017 @default.
- W4387209967 hasConceptScore W4387209967C2778690821 @default.
- W4387209967 hasConceptScore W4387209967C2779075594 @default.
- W4387209967 hasConceptScore W4387209967C2779134260 @default.
- W4387209967 hasConceptScore W4387209967C2780942790 @default.
- W4387209967 hasConceptScore W4387209967C2781197716 @default.
- W4387209967 hasConceptScore W4387209967C55493867 @default.
- W4387209967 hasConceptScore W4387209967C71924100 @default.
- W4387209967 hasConceptScore W4387209967C74172505 @default.
- W4387209967 hasConceptScore W4387209967C90924648 @default.
- W4387209967 hasIssue "5" @default.
- W4387209967 hasLocation W43872099671 @default.
- W4387209967 hasOpenAccess W4387209967 @default.
- W4387209967 hasPrimaryLocation W43872099671 @default.
- W4387209967 hasRelatedWork W1921717516 @default.
- W4387209967 hasRelatedWork W1972654344 @default.
- W4387209967 hasRelatedWork W2056065139 @default.
- W4387209967 hasRelatedWork W2056067227 @default.
- W4387209967 hasRelatedWork W2066486616 @default.
- W4387209967 hasRelatedWork W2122443163 @default.
- W4387209967 hasRelatedWork W2155353257 @default.
- W4387209967 hasRelatedWork W4309888487 @default.
- W4387209967 hasRelatedWork W4313384767 @default.
- W4387209967 hasRelatedWork W4313386619 @default.
- W4387209967 hasVolume "78" @default.
- W4387209967 isParatext "false" @default.
- W4387209967 isRetracted "false" @default.
- W4387209967 workType "article" @default.